ISAR-REACT 5 Surprises Investigators: Prasugrel Shows Benefit Over Ticagrelor in ACS Patients
Prasugrel showed significant benefit as compared with ticagrelor in patients with acute coronary syndrome (ACS) with and without ST-elevation myocardial infarction (STEMI), according to results presented Sunday at the European Society of Cardiology Congress in Paris.